Microbiology Department, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, 23116, Indonesia.
Pharmacology Department, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, 23116, Indonesia.
J Res Health Sci. 2024 Mar 18;24(1):e00601. doi: 10.34172/jrhs.2024.136. Epub 2024 Mar 15.
Indonesia has the second highest tuberculosis (TB) cases globally. This study aimed to determine the sociodemographic factors associated with TB and rifampicin-resistant tuberculosis (RR-TB) cases among presumptive pulmonary TB patients in Aceh Referral Hospital. A retrospective cross-sectional study.
A retrospective cross-sectional review of presumptive pulmonary TB patients having a sputum test at the clinical microbiology laboratory was conducted from January 2015 to December 2021. Patient characteristics and drug susceptibility data were abstracted from the hospital information system of TB (SITB) and analyzed by univariate and bivariate analysis.
The (MTB) was detected in 32.8% sample (1,521/4,637). Of the TB-confirmed cases, 14.1% (215/1,521) were resistant to rifampicin (RR-TB). Most of them were male patients (71.63%), were in the age range of 35-54 years (48.7%), lived in rural areas of the country (56.3%), and were previously TB-treated cases (65.5%). Overall, 35-44-year-old patients (adjusted odds ratio [AOR]=2.11, 95% CI=1.25, 3.5, <0.05) were more likely to have RR-TB compared to>65-year-old patients. Gender and residence were not associated with RR-TB (>0.05). Case detection decreased in pandemic conditions (19.5% in 2019 to 13.9% and 7.91% in 2020 and 2021, respectively).
The findings revealed the dynamic cases and sociodemographic factors of TB and RR-TB in a province referral hospital in Indonesia for 7 years. The cases of TB and RR-TB among presumptive TB patients were 32.8% and 14.1%, respectively. The cases were found to be more noticeable in males, adults (45-54 years old), and patients residing in rural areas.
印度尼西亚是全球结核病(TB)病例第二高的国家。本研究旨在确定与亚齐转诊医院疑似肺结核患者的 TB 和利福平耐药结核病(RR-TB)病例相关的社会人口学因素。 一项回顾性横断面研究。
对 2015 年 1 月至 2021 年 12 月在临床微生物学实验室进行痰检的疑似肺结核患者进行回顾性横断面研究。从结核病医院信息系统(SITB)中提取患者特征和药物敏感性数据,并进行单变量和双变量分析。
MTB 在 32.8%的样本(1,521/4,637)中被检测到。在确诊的 TB 病例中,14.1%(215/1,521)对利福平耐药(RR-TB)。他们大多数是男性患者(71.63%),年龄在 35-54 岁之间(48.7%),居住在农村地区(56.3%),并且是以前接受过 TB 治疗的病例(65.5%)。总体而言,与>65 岁的患者相比,35-44 岁的患者(调整后的优势比 [AOR]=2.11,95%CI=1.25,3.5,<0.05)更有可能患有 RR-TB。性别和居住地与 RR-TB 无关(>0.05)。在大流行期间,病例检出率下降(2019 年为 19.5%,2020 年和 2021 年分别为 13.9%和 7.91%)。
本研究结果揭示了印度尼西亚一家省级转诊医院 7 年来的 TB 和 RR-TB 动态病例和社会人口学因素。疑似肺结核患者中 TB 和 RR-TB 的发生率分别为 32.8%和 14.1%。男性、成年人(45-54 岁)和农村地区的患者中发现了更多的病例。